SCHEMBL21045189

SCHEMBL21045189

Cc1cc(C(=O)NCCCc2ccc(-c3cnc4[nH]ncc4c3)cc2)n(C)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3C3 Q8NEB9 3/20 0.40
TNIK Q9UKE5 1/20 0.39
CNR1 P21554 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HDAC3 O15379 2/20 0.39
HDAC4 P56524 2/20 0.39
HDAC1 Q13547 2/20 0.39
HDAC2 Q92769 2/20 0.39
HDAC8 Q9BY41 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC9 Q9UKV0 1/20 0.39
HDAC5 Q9UQL6 1/20 0.39
MAPT P10636 1/20 0.38
FLT3 P36888 2/20 0.38
STING1 Q86WV6 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21045216 0.89 ROCK2 (0.47) CNR1HDAC3HDAC4HDAC1HDAC2
SCHEMBL29411391 0.89 ROCK2 (0.47) CNR1HDAC3HDAC4HDAC1HDAC2
SCHEMBL21045205 0.88 FLT3 (0.51) FLT3
SCHEMBL21045085 0.87 HDAC3 (0.38) CNR1L3MBTL1HDAC3HDAC4HDAC1
SCHEMBL21045260 0.82 KDM4E (0.52) NAMPTPTAFR
SCHEMBL21045409 0.81 CACNA1H (0.43) CNR1L3MBTL1HDAC3HDAC4HDAC1
SCHEMBL21045404 0.80 DRD5 (0.47) L3MBTL1HDAC3HDAC4HDAC1HDAC2
SCHEMBL29411424 0.80 DRD5 (0.47) L3MBTL1HDAC3HDAC4HDAC1HDAC2
SCHEMBL21045362 0.79 DYRK1A (0.45) CNR1HDAC1HDAC6MAPTPTAFR
SCHEMBL21045541 0.79 PDK1 (0.40) CNR1L3MBTL1HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188035-A1 TUBULIN INHIBITORS LIN BIOSCIENCE LLC (US) 2025-06-12 US disclosed
US-12247010-B2 Tubulin inhibitors LIN BIOSCIENCE INC. (TW) 2025-03-11 US disclosed
US-20220089539-A1 TUBULIN INHIBITORS LIN BIOSCIENCE INC. (TW) 2022-03-24 US disclosed
US-20220089539-A1 TUBULIN INHIBITORS LIN BIOSCIENCE INC. (TW) 2022-03-24 US disclosed
US-11040945-B2 Tubulin inhibitors LIN BIOSCIENCE PTY LTD. 2021-06-22 US disclosed
US-11040945-B2 Tubulin inhibitors LIN BIOSCIENCE PTY LTD. 2021-06-22 US disclosed
WO-2019113242-A1 TUBULIN INHIBITORS Lin BioScience, LLC (US) 2019-06-13 WO disclosed
US-20190169127-A1 TUBULIN INHIBITORS LIN BIOSCIENCE INC. (TW) 2019-06-06 US disclosed
US-20190169127-A1 TUBULIN INHIBITORS LIN BIOSCIENCE INC. (TW) 2019-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220089539-A1 TUBULIN INHIBITORS TUBB3, TUBB1, TUBB PIK3C3 975/4885TNIK 1097/4885CNR1 4572/4885
US-12247010-B2 Tubulin inhibitors TUBB3, TUBB1, TUBB PIK3C3 975/4885TNIK 1097/4885CNR1 4572/4885
US-11040945-B2 Tubulin inhibitors TUBB3, TUBB1, TUBB PIK3C3 975/4885TNIK 1097/4885CNR1 4572/4885
US-20250188035-A1 TUBULIN INHIBITORS TUBB3, TUBB1, TUBB PIK3C3 975/4885TNIK 1097/4885CNR1 4572/4885
US-20190169127-A1 TUBULIN INHIBITORS TUBB3, TUBB1, TUBB PIK3C3 975/4885TNIK 1097/4885CNR1 4572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.